Cite
HARVARD Citation
Gomez-Roca, C. et al. (2019). Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages. Annals of oncology. pp. 1381-1392. [Online].